Drug Topics

NOVEMBER 3, 2023

During a session at AMCP Nexus, presenters discussed the delicate balance between cost and innovation as it relates to forthcoming oncology treatments.

98

98

Pharmaceutical Technology

FEBRUARY 10, 2023

On November 22, 2022, the FDA approved CSL Behring’s Hemgenix (etranacogene dezaparvovec), the first gene therapy treatment for hemophilia B, with a staggering manufacturer price of $3.5 million, according to GlobalData’s Price Intelligence (POLI), making it the most expensive drug in the world.

FDA 105

FDA 105

pharmaphorum

JANUARY 11, 2021

US biotech bluebird bio has announced plans to split into two this year, with a separate oncology business spinning off as the company prepares to bring its products to market. Meanwhile the as-yet unnamed oncology company will spin off under the leadership of bluebird’s current chief executive Nick Leschly. million price tag.

FDA 60

FDA 60

Pharmaceutical Technology

MAY 2, 2023

Immuno-oncology (IO) agents have transformed the cancer therapeutics landscape, driving long-term remissions in a subset of patients who historically had limited options. IO therapies come with a hefty price tag, with ICI therapies in the US typically exceeding $100,000, while cell therapies can exceed $400,000.

Immunization 52

Immunization Vaccines 52

The Physician Pharmacist

SEPTEMBER 14, 2023

Just for example, I loved oncology class. I in that I did a Clinical Oncology rotation at the Johns Hopkins Hospital in Baltimore, and hated it. It's funny because I remember, you know, my Hopkins rotation and I absolutely loved my oncology, you know, rotation, but you're the opposite of that. But I also hated cardiology.

Medical Schools 52

Medical Schools Hospitals Communication Patient Care 52

European Pharmaceutical Review

DECEMBER 27, 2023

This is in addition to its considerable price tag. About the author Professor Arnon Nagler, MD is President of the Hemato-Oncology Center and director of the Division of Hematology and the Bone Marrow Transplantation and Cord Blood Bank at the Sheba Medical Center, and Professor of Medicine at Tel Aviv University in Israel.

Adverse Reactions 85

Adverse Reactions Immunization Medical Schools Chemotherapy 85

Pharmaceutical Technology

MARCH 17, 2023

On 16 March, Watt spoke at GlobalData webinar titled “Pharma [POLI]: Market Access Risk Outlook”, providing a current outlook on the pharmaceutical pricing and reimbursement environments around the world, including key reforms, risks and opportunities. This may be because access to oncology drugs varies widely across the world, she added.

Pharmaceutical Companies 102

Pharmaceutical Companies Pharmaceutical Companies Communication 102